Campaigners are raising concerns that babies like Jesy Nelson’s twins, who suffer from a debilitating muscle wasting disease, are being neglected by the government. Parents of infants with spinal muscular atrophy (SMA), including the former Little Mix singer, recently participated in an MPs debate urging universal testing for the condition at birth. While NHS treatments are now considered a potential cure, they must be administered shortly after birth to prevent irreversible nerve damage during the early weeks of life.
During an update provided by health minister Sharon Hodges, it was disclosed that an NHS pilot program was still hesitant to expand testing to over 160,000 newborns annually due to concerns about the overall benefits versus risks of screening. Campaigners have expressed disappointment following the resignation of previous health secretary Wes Streeting, who had pledged to explore extending screening to all newborns, implying a shift in government commitment under his successor, James Murray.
SMA UK reported that since Streeting’s promise to consider nationwide testing, approximately 12 newborns with SMA may have been born every 12 weeks without being tested. This delay in diagnosis could lead to delayed treatment and increased health complications for affected infants. Giles Lomax, CEO of SMA UK, voiced frustration over the lack of urgency from the government in addressing the issue, emphasizing the critical need for immediate action to support affected families.
Despite a delayed start to the NHS pilot program in England, Streeting’s intervention had accelerated its launch from January 2027 to October of the current year. However, plans to exclude a significant number of newborns from testing for comparison purposes have sparked further criticism from advocates. The debate in Parliament witnessed widespread support from MPs urging the government to expand SMA screening nationwide.
In response to mounting pressure, Health Minister Sharon Hodgson acknowledged the concerns raised by families and advocates regarding the slow progress towards implementing SMA screening. She emphasized the importance of thorough evaluation to ensure that screening initiatives are effective and safe, with a focus on maximizing NHS resources for the benefit of infants in need.
International data highlights the positive impact of early screening for SMA, with countries like most of Europe already adopting this practice as part of routine newborn testing. Campaigners continue to advocate for equitable access to screening for rare diseases like SMA, emphasizing the urgency of government intervention to prevent unnecessary suffering and improve health outcomes for affected infants. Jesy Nelson’s collaboration with the Mirror in advocating for expanded SMA screening underscores the pressing need for action to address this critical issue affecting newborns nationwide.
